After decades of relatively little progress, patients with CKD are finally getting access to promising new kidney drugs. We’re optimistic about a new chapter in kidney disease management, fueled by an active pipeline of new and innovative medications. Here are a few notable drugs that have been making headlines in the kidney care industry. SGLT-2…
Read More
Chronic kidney disease represents a broad group of patients, ranging from those at risk of kidney disease (CKD 1) to those with advanced decline in kidney function (CKD 5). Whatever their stage, the ultimate goal in CKD treatment is to preserve kidney function as much as possible. Ultimately, this keeps patients out of the hospital…
Read More